Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines ...Middle East

PR Newswire - News
Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines
TAIZHOU, China, Aug. 18, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Company has completed the subject enrollment and dosing for the comparative Phase II clinical trial between its...

Hence then, the article about completion of subject enrollment and vaccination for the comparative study between recov and mrna vaccines was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News